Detalhe da pesquisa
1.
Prospective trial of natalizumab personalised extended interval dosing by therapeutic drug monitoring in relapsing-remitting multiple sclerosis (NEXT-MS).
J Neurol Neurosurg Psychiatry
; 95(5): 392-400, 2024 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37963723
2.
Disease progression in the first 5 years of treatment in multiple sclerosis: Predictive value of early brain and lesion volume changes.
Mult Scler
; 30(1): 44-54, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38018502
3.
Serum glial fibrillary acidic protein in natalizumab-treated relapsing-remitting multiple sclerosis: An alternative to neurofilament light.
Mult Scler
; 29(10): 1229-1239, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37530045
4.
Neurophysiological MEG markers of cognitive impairment and performance validity in multiple sclerosis.
Mult Scler
; 29(8): 1001-1011, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36964707
5.
Mapping the risk of infections in patients with multiple sclerosis: A multi-database study in the United Kingdom Clinical Practice Research Datalink GOLD and Aurum.
Mult Scler
; 28(11): 1808-1818, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35575214
6.
The MSIS-29 and SF-36 as outcomes in secondary progressive MS trials.
Mult Scler
; 28(10): 1606-1619, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35876467
7.
Disability in multiple sclerosis is related to thalamic connectivity and cortical network atrophy.
Mult Scler
; 28(1): 61-70, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33870779
8.
Natalizumab concentrations during pregnancy in three patients with multiple sclerosis.
Mult Scler
; 28(2): 323-326, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34931887
9.
Neurofilament-light and contactin-1 association with long-term brain atrophy in natalizumab-treated relapsing-remitting multiple sclerosis.
Mult Scler
; 28(14): 2231-2242, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36062492
10.
Personalized B-cell tailored dosing of ocrelizumab in patients with multiple sclerosis during the COVID-19 pandemic.
Mult Scler
; 28(7): 1121-1125, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34240631
11.
Use of follow-on disease-modifying treatments for multiple sclerosis: Consensus recommendations.
Mult Scler
; 28(14): 2177-2189, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36000489
12.
Differential item functioning of the Arm function in Multiple Sclerosis Questionnaire (AMSQ) by language, a study in six countries.
Mult Scler
; 27(1): 90-96, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31845614
13.
Increased functional sensorimotor network efficiency relates to disability in multiple sclerosis.
Mult Scler
; 27(9): 1364-1373, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33104448
14.
Functional brain network organization measured with magnetoencephalography predicts cognitive decline in multiple sclerosis.
Mult Scler
; 27(11): 1727-1737, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33295249
15.
Minimal clinically important difference of improvement on the Arm Function in Multiple Sclerosis Questionnaire (AMSQ).
Mult Scler
; 26(4): 505-508, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30657002
16.
Infusion-related events during natalizumab: No need for post-infusion monitoring.
Mult Scler
; 26(12): 1590-1593, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31237826
17.
Leveraging real-world data to investigate multiple sclerosis disease behavior, prognosis, and treatment.
Mult Scler
; 26(1): 23-37, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31778094
18.
Infratentorial and spinal cord lesions: Cumulative predictors of long-term disability?
Mult Scler
; 26(11): 1381-1391, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31373535
19.
The clinical value of the patient-reported multiple sclerosis neuropsychological screening questionnaire.
Mult Scler
; 25(11): 1543-1546, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29775164
20.
Tasks of activities of daily living (ADL) are more valuable than the classical neurological examination to assess upper extremity function and mobility in multiple sclerosis.
Mult Scler
; 25(12): 1673-1681, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30168739